Cancer Research
Cancer Research with Small Molecules
From Bench to Targeted Therapy
Small molecules are invaluable tools in cancer research, offering a versatile approach to understanding, diagnosing, and treating cancer. Typically consisting of a few hundred atoms, these chemical compounds play a pivotal role across the discovery pipeline — from target validation and pathway dissection to clinical drug development. Adooq supplies high-purity inhibitors, degraders, reference compounds, and screening libraries covering every major cancer pathway.
Targeted Therapies
Inhibitors blocking specific oncogenic proteins or pathways — including tyrosine kinase inhibitors like imatinib for chronic myeloid leukemia.
Chemoprevention
SERMs such as tamoxifen reduce the risk of cancer initiation or recurrence in high-risk populations through selective receptor modulation.
Diagnostic Probes
Imaging-labeled small molecules enable detection of cancer markers via PET, MRI, and fluorescence-based modalities.
Drug Resistance Studies
Tool compounds illuminate resistance mechanisms — from kinase mutations to efflux pumps — and seed strategies to overcome them.
Browse by Cancer Type
Explore our curated catalogs of small molecule inhibitors, degraders, and reference compounds organized by major cancer indication. Each collection is mapped to subtype-specific pathways and clinically validated targets.
Cancer Research Products by Pathway
Mechanism-focused compound collections grouped by biological process. Click any theme to browse inhibitors, agonists, and chemical probes targeting that pathway.
Tumor Initiation & Growth
Metabolism & Regulation
Immune & Microenvironment
Emerging Modalities
In summary, small molecules are indispensable tools in cancer research — enabling the development of targeted therapies, supporting early diagnosis, and illuminating the complexities of cancer biology and drug resistance. Their adaptability and precision make them essential in the ongoing fight against cancer.
